Development and Validation of a New Nomogram for Predicting Medication Nonadherence Risk in a Chinese Hyperlipidemia
Jingyue Guo1, Feng Ning2, Jianbiao Xiao2
1Medical Department, Dahongmen Community Health Service Center, Beijing, 100075, People's Republic of China.
Patient Preference and Adherence
|January 5, 2026
Summary
This study identified key factors for medication nonadherence in Chinese hyperlipidemia patients. A developed nomogram model accurately predicts nonadherence risk, aiding personalized interventions for better treatment outcomes.
Area of Science:
- Cardiovascular Medicine
- Pharmacoeconomics
- Clinical Pharmacy
Background:
- Hyperlipidemia poses a significant cardiovascular risk, necessitating consistent medication adherence.
- Suboptimal medication adherence is a prevalent issue impacting treatment efficacy in hyperlipidemia management.
- Understanding factors influencing adherence is crucial for developing targeted interventions.
Purpose of the Study:
- To investigate factors associated with medication nonadherence in a Chinese hyperlipidemia population.
- To develop and validate a predictive nomogram for medication nonadherence risk.
- To assess the impact of pharmaceutical interventions on medication adherence and lipid profiles.
Main Methods:
- A prospective intervention study involving 685 hyperlipidemia patients in Beijing (Nov 2020-Oct 2021).
- Medication adherence assessed using a 9-question scale, followed by pharmacist-led interventions for nonadherent patients.
- Multivariate logistic regression and nomogram construction used for risk factor analysis and prediction model development. Model accuracy evaluated using AUC and C-index.
Main Results:
- The medication nonadherence rate was 34.75% (238 patients).
- Post-intervention, adherence scores significantly improved (p < 0.001), with improvements in TC, TG, LDL-C, and HDL-C levels.
- Five predictors identified for the nomogram: hyperlipidemia duration, adherence to doctor's visits, empirical medication use, physical exercise, and lifestyle compliance. AUC=0.927, C-index=0.87.
Conclusions:
- Hyperlipidemia patients exhibit low medication adherence, which can be improved through pharmaceutical interventions.
- A validated nomogram effectively predicts individual medication nonadherence risk in hyperlipidemia patients.
- The study highlights the importance of personalized risk assessment and intervention strategies for optimizing hyperlipidemia management.
Related Concept Videos
01:23Dosage Regimen Designs: Nomograms and Tabulations
152
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
152
01:15Drug Dosing: Geriatric Patients
206
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
206
01:21Drug Dosing: Obese Patients
195
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
195
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
133
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
133